Chinese yam starch and non-starch polysaccharides alleviated antibiotic-associated diarrhea by ameliorating intestinal inflammation and regulating intestinal microbiotas
Related Experiment Video
Updated: Sep 19, 2025

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Qing Zhang1, Qing Wang1, Fei Zhang1
1School of Pharmacy, Henan University of Chinese Medicine, Henan, China.
Background:
Yam is a typical food and can also be used as traditional medicine in treating diarrhea. Yam non-starch polysaccharides (SYP) and starch (SYS) are the most abundant ingredients in yam. The present study aimed to study the antidiarrheal effects and potential mechanisms of SYP and SYS on antibiotic-associated diarrhea (AAD) rats.
Results:
A rat model of antibiotic-associated diarrhea was prepared by orally administering a mixed antibiotic solution once a day for 10 consecutive days. Then, the rats were orally administered with SYS and SYP once a day for 7 consecutive days to treat antibiotic associated diarrhea. Fecal water content, colonic histopathology, inflammatory cytokines and intestinal microbiotas were used to evaluate the antidiarrheal effect and elucidate the potential mechanism. SYP and SYS reduced the fecal water content, improved the integrity of the colonic mucosa and alleviated the colonic inflammatory response of AAD rats. Moreover, SYP and SYS significantly increased the abundance and diversity of intestinal microbiotas in AAD rats. The relative abundance of Enterococcus, Lachnoclostridium, Bacteroides, Clostridioides, Clostridiales_unclassified, Serratia and Lachnospiraceae_NK4A136_group had significantly changed in the model (antibiotic control) group. The abundance of Enterococcus, Bacteroides, Clostridioides, Clostridiales_unclassified, Serratia and Lachnospiraceae_NK4A136_group was restored after treatment with SYS. The abundance of Enterococcus, Clostridioides and Serratia was recalled after SYP treatment.
Conclusion:
SYS and SYP could improve antibiotic-associated diarrhea by ameliorating the colon inflammatory response and rebuilding intestinal microbiotas. © 2025 Society of Chemical Industry.
More Related Videos
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
03:48Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Related Concept Videos
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...